- Theme Cancer Pharmacists, Clinical Trials & Research Professionals
- Resource Type Position Statement
- DATE 10 March 2023
Update: Safe handling of monoclonal antibodies in healthcare settings
This position statement was published in the Asia Pacific Journal of Clinical Oncology, 10 March 2023, https://doi.org/10.1111/ajco.13943
The aims were to (a) review the scientific literature on occupational risk, including exposure mechanisms and risk assessment, with regards to handling monoclonal antibodies (mABs) in healthcare settings; and (b) update the recommendations in the Clinical Oncology Society of Australia (COSA) safe handling of monoclonal antibodies in healthcare settings position statement, published in 2013.
Practitioners should follow the 14 recommendations to lower occupational risk when handling mABs. Another Position Statement update should occur in 5–10 years to ensure the currency of recommendations.
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 3 days ago
RT by @cosaoncology: Final days to register for the upcoming COGNO Annual Scientific Meeting! Sunday 13 Oct – Tuesday 15 Oct. Register here bit.ly/4ehF01y #COGNO24 @COSAoncology
Read More >COSAoncology 3 days ago
We are pleased that Bloomhill Cancer Care have renewed their Associated membership. COSA look forward to our ongoing collaboration to improve cancer care and control. Bloomhill members can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >COSAoncology 9 days ago
Congrats @RebeccaVenchers @COSA_Surviv Fellow and your co-authors on the publication of your survivorship research @bogda_koczwara @hagsie @M_Jefford
Read More >COSAoncology 9 days ago
Congrats @mijancoubd @COSA_Surviv Fellow and your co-authors on the publication of this important work @rayychan @bogda_koczwara @dr_elysia @garvey_gail
Read More >COSAoncology 16 days ago
RT by @cosaoncology: Register for COGNO ASM, Oct 14-15, Melbourne. Precision Targets: Personalised Care in Neuro-Oncology feat @herveyjumpe & Prof Dunbar. Keynotes & collab opportunities for clinicians, researchers & allied health. Improve patient outcomes together! #COGNO24 bit.ly/4ehF01y
Read More >COSAoncology 24 days ago
RT by @cosaoncology: REMINDER: The Inspirational Research Grant closes 30 Sept. That gives you 2 weeks to get your application in! If you're on the fence about applying, here are the recipients of the 2024 grants and their projects Read More: buff.ly/3B3fZIQ Apply: buff.ly/4dS0amR
Read More >COSAoncology 29 days ago
Earlybird registration for the 2024 COSA ASM closes tomorrow! Join or renew as a COSA member now and you'll get a further discount valued at more than the cost of your COSA membership: bit.ly/3hXsDLm
Read More >COSAoncology one month ago
RT by @cosaoncology: Our Supportive Care 2030 Movement Ambition Statements are now published in the @TheLancet's @eClinicalMed. @CancerCareMASCC as the pre-eminent leader in #supponc will work with our partners around the globe to achieve these share ambitions. Full Article tinyurl.com/2b3ksu9e
Read More >COSAoncology one month ago
Earlybird discounts close this Friday for #COSA2024. Review the packed program cosa-2024.p.asnevents.com.au and register today to join us on the Gold Coast in November. #cancer #Oncology
Read More >COSAoncology one month ago
RT by @cosaoncology: Be part of the largest medical radiation event in Australasia! We are thrilled to invite all members of the medical radiation science community to submit abstracts for oral presentations and poster exhibits at ASMIRT/NZIMRT 2025 Conference. 🔗 conference.asmirt.org/nzimrt2025/abs…
Read More >